Article
A novel amplification of JAK2 in a case of relapsed pediatric B-ALL
2024-01-31
Abstract excerpt
B-cell acute lymphoblastic leukemia (B-ALL) is a heterogeneous disease wherein cytogenetics comprises an independent prognostic factor. Cytogenetic subgroups like B-ALL with t(9;22), MLL rearrangement, hypodiploidy, and Ph-like ALL are stratified as high-risk and are treated on the high-risk regimen. However, a subset that does not fall into a specific cytogenetic risk groups, is classified as cytogenetics NOS (No...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a011889f-2a0b-522d-ab64-7ce3675f8181
- DOI
- 10.22541/au.170669017.79417715/v1
